For help on how to get the results you want, see our search tips.
58 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Referral type
Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter
Articles 39 and 40 Remove Articles 39 and 40 filter
Article 107i procedures Remove Article 107i procedures filter
Article 78 Remove Article 78 filter
Article 34 Remove Article 34 filter
-
List item
Referral: Hydroxyethyl starch (HES) containing medicinal products
hydroxyethyl starch, Article 107i procedures
Status: European Commission final decision, opinion/position date: 26/10/2017, EC decision date: 17/07/2018, Last updated: 11/02/2022 -
List item
Referral: Fenspiride containing medicinal products
fenspiride, Article 107i procedures
Status: CMDh final position, opinion/position date: 29/05/2019, Last updated: 26/06/2019 -
List item
Referral: Fortekor
benazepril hydrochloride, Article 34
Status: European Commission final decision, opinion/position date: 10/11/2011, EC decision date: 06/02/2012, Last updated: 11/03/2019 -
List item
Referral: Girolan and its associated name Apralan
apramycin sulfate, associated names: Apralan, Article 34
Status: European Commission final decision, Last updated: 15/06/2018 -
List item
Referral: Lincocin and its associated names
lincomycin, Article 34
Status: European Commission final decision, opinion/position date: 13/07/2017, EC decision date: 05/10/2017, Last updated: 14/11/2017 -
List item
Referral: Denagard 45%
tiamulin hydrogen fumarate, associated names: Tiamutin 45%, Denagard 450 mg/g, Denagard vet 450 mg/g, Article 34
Status: European Commission final decision, opinion/position date: 12/04/2017, EC decision date: 14/07/2017, Last updated: 11/08/2017 -
List item
Referral: Closamectin Pour-on Solution and associated names
ivermectin, closantel, Article 78
Status: European Commission final decision, opinion/position date: 08/10/2015, EC decision date: 22/03/2016, Last updated: 31/05/2016 -
List item
Referral: Baytril injectable
enrofloxacin, Article 34
Status: European Commission final decision, opinion/position date: 09/04/2014, EC decision date: 01/09/2014, Last updated: 10/12/2014 -
List item
Referral: Linco-Spectin 100 and associated names
lincomycin, spectinomycin, Article 34
Status: European Commission final decision, opinion/position date: 10/04/2014, EC decision date: 11/07/2014, Last updated: 04/09/2014 -
List item
Referral: Dectomax injectable solution and its associated names
doramectin, associated names: Dectomax 1% Injektionslösung für Rinder und Schafe, Dectomax Vet, Dectomax 1%, Dectomax 1% Injectable Solution, Prontax, Dectomax solution injectable, Dectomax Injectable Solution for Cattle and Sheep, Article 34
Status: European Commission final decision, opinion/position date: 08/12/2004, EC decision date: 29/03/2005, Last updated: 13/08/2014 -
List item
Referral: Eprinex pour-on and its associated names
eprinomectin, associated names: Eprinex - Lösung zum Auftragen auf die Haut für Rinder, Eprinex Vet, Eprinex pour-on vet, Eprinex pour on pour bovins, Eprinex Pour-On for beef and dairy cattle, Ivomec-Eprinex Pour On voor vlees- en melkvee, Article 34
Status: European Commission final decision, opinion/position date: 11/02/2004, EC decision date: 11/08/2004, Last updated: 11/08/2014 -
List item
Referral: Bayovac IBR Marker Vivum
bovine Herpes Virus type 1 (BHV-1), strain Difivac (IBR-Marker Virus, gE-negative), modified live (attenuated) virus, associated names: Rhinobovin, Marker lebend, Rhinobovin Marker live, RhinobovinMarker Viva, Rhinobovin Marker Attenuato, Rhinobovin Marker Viva Marcada, Article 78
Status: European Commission final decision, opinion/position date: 21/01/2000, EC decision date: 10/07/2000, Last updated: 05/08/2014 -
List item
Referral: Methadone medicinal products for oral use containing povidone
methadone, Article 107i procedures
Status: CMDh final position, opinion/position date: 23/07/2014, Last updated: 04/08/2014 -
List item
Referral: Hydroxyethyl starch solutions for infusion
hydroxyethyl starch, Article 107i procedures
Status: European Commission final decision, opinion/position date: 23/10/2013, EC decision date: 19/12/2013, Last updated: 06/03/2014 -
List item
Referral: Flupirtine-containing medicines
flupirtine, Article 107i procedures
Status: European Commission final decision, opinion/position date: 26/06/2013, EC decision date: 05/09/2013, Last updated: 21/11/2013 -
List item
Referral: Micotil 300 Injectie
tilmicosin, Article 34
Status: European Commission final decision, opinion/position date: 18/07/2013, EC decision date: 18/10/2013, Last updated: 20/11/2013 -
List item
Referral: Numeta G13%E and Numeta G16%E emulsion for infusion
Article 107i procedures
Status: CMDh final position, opinion/position date: 18/09/2013, Last updated: 27/09/2013 -
List item
Referral: Cyproterone- and ethinylestradiol-containing medicines
cyproterone, ethinyl estradiol, associated names: Acnemine, Acneson, Chloe, Clairette, Cyprest, Cyprodiol, Diane 35, Dianette, Feminil, Minerva, Zyrona, Article 107i procedures
Status: European Commission final decision, opinion/position date: 29/05/2013, EC decision date: 25/07/2013, Last updated: 05/08/2013 -
List item
Referral: Tetrazepam-containing medicines
tetrazepam, associated names: Myolastan and generics, Article 107i procedures
Status: European Commission final decision, opinion/position date: 24/04/2013, EC decision date: 29/05/2013, Last updated: 18/07/2013 -
List item
Referral: Ethinylestradiol-Drospirenone 24+4
ethinyl estradiol, drospirenone, associated names: Yaz 24+4, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 06/07/2012, Last updated: 11/01/2013 -
List item
Referral: Yaz 24+4
ethinylestradiol, drospirenone, associated names: Ethinylestradiol-Drospirenone 24+4, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 03/07/2012, Last updated: 11/01/2013 -
List item
Referral: Baytril 10% oral solution
enrofloxacin, Article 34
Status: European Commission final decision, opinion/position date: 14/06/2012, EC decision date: 08/10/2012, Last updated: 20/11/2012 -
List item
Referral: Milaxyn Plus
praziquantel, pyrantel, febantel, associated names: Strantel Plus, Prazical Plus, Voxical Plus, Exitel Plus, Cazitel Plus and Prazitel Plus, Article 34
Status: European Commission final decision, opinion/position date: 07/03/2012, EC decision date: 18/06/2012, Last updated: 23/07/2012 -
List item
Referral: Valproat Ratiopharm Chrono
valproic acid, valproate, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 25/05/2010, EC decision date: 26/05/2010, Last updated: 23/07/2012 -
List item
Referral: Hiprabovis Pneumos
Mannheimia haemolytica biotype A serotype A1, inactivated cell free suspension containing leukotoxoid Ph. Eur., inactivated Histophilus somni Bailie strain, Article 78
Status: European Commission final decision, opinion/position date: 14/07/2011, EC decision date: 03/11/2011, Last updated: 12/12/2011